Trial intelligence / Profile preview

Feasibility of endogenous glucose production measurement during a hypoglycaemic clamp in type 1 diabetes

2013-004527-36Phase 4Completed

Sponsor
Medical University of Graz
Start
Nov 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of human insulin in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz. Primary endpoint: Stable tracer-to-tracee ratio during variable glucose infusion rate. Started Nov 2013; status: completed.

02

Drugs

human insulin
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2013-004527-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004527-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call